IQ · iQIYI, Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-11 | Yang Xianghua |
Senior Vice President |
Award↑
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
4,812,117 |
| 2026-05-11 | Duan Youqiao |
Senior Vice President |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
375,056 |
| 2026-05-11 | Wang Xiaohui |
Chief Content Officer |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
1,531,250 |
| 2026-05-11 | Yang Xianghua |
Senior Vice President |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
5,600,000 |
| 2026-05-11 | Wang Xiaohui |
Chief Content Officer |
Award↑
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
1,531,250 |
| 2026-05-11 | Wang Xiaohui |
Chief Content Officer |
Award↑
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
7,500,000 |
| 2026-05-11 | Duan Youqiao |
Senior Vice President |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
3,200,000 |
| 2026-05-11 | Zeng Ying Ms. |
Interim CFO |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
700,000 |
| 2026-05-11 | Duan Youqiao |
Senior Vice President |
Award↑
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
375,056 |
| 2026-05-11 | Yang Xianghua |
Senior Vice President |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
4,812,117 |
| 2026-05-11 | Zeng Ying Ms. |
Interim CFO |
Award↑
Filing footnotes — Option (rignt to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (rignt to buy)
|
480,056 |
| 2026-05-11 | Duan Youqiao |
Senior Vice President |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 08/05/2026) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 08/05/2016, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
982,927 |
| 2026-05-11 | Wang Xiaohui |
Chief Content Officer |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
7,500,000 |
| 2026-05-11 | Duan Youqiao |
Senior Vice President |
Award↑
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 08/05/2026) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 08/05/2016, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
982,927 |
| 2026-05-11 | Duan Youqiao |
Senior Vice President |
Award↑
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
3,200,000 |
| 2026-05-11 | Zeng Ying Ms. |
Interim CFO |
Other↓
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
480,056 |
| 2026-05-11 | Yang Xianghua |
Senior Vice President |
Award↑
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
5,600,000 |
| 2026-05-11 | Zeng Ying Ms. |
Interim CFO |
Award↑
Filing footnotes — Option (right to buy) (Direct)
The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
Option (right to buy)
|
700,000 |